Stay updated on Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial
Sign up to get notified when there's something new on the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page.

Latest updates to the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page
- Check5 days agoChange DetectedPage revision updated from v3.6.6 to v3.7.0, indicating deployment of a newer page template; the study content and fields remain unchanged.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now shows revision v3.6.6, replacing the previous v3.6.5. This reflects a behind-the-scenes update to the site's template and does not alter the clinical trial details presented.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5. This signals a minor version update to the page without changing substantive content.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous version, indicating a small backend or UI update without changes to study information.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision: v3.6.0 has been replaced by Revision: v3.6.3 on the page, indicating a small version update to the page labeling. This change does not alter any study content or data displayed.SummaryDifference0.0%

- Check97 days agoChange DetectedNew study navigation/help sections have been added (How to Read a Study Record, Common Questions, How to Join a Study). The recruitment status was updated to 'No longer looking for participants', and there are minor formatting changes to the Intervention/Treatment label along with a revision update to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemcitabine/Nab-paclitaxel ± FG-3019 Clinical Trial page.